Earnings History Data for Humacyte, Inc. (HUMA) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Humacyte, Inc.

Humacyte Inc. is a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale. Humacyte Inc., formerly known as Alpha Healthcare Acquisition Corp., is based in DURHAM, N.C.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
08-11-2024	PM		HUMA	Humacyte, Inc.	648.08	-0.33	-0.25	-0.25	Humacyte GAAP EPS of -$0.33 misses by $0.08 [11/8/2024 8:10 AM]	5.75	0.49 (9.22%)	5.18	-0.08 (-1.52%)	2.08 - 9.97	5,800,106	2,660,000	171,088
Humacyte Q3 2024 Earnings Preview [11/7/2024 1:04 PM] Humacyte GAAP EPS of -$0.33 misses by $0.08 [11/8/2024 8:10 AM] Humacyte rises 6% as regulators reviewing bioengineered human tissue asset [11/8/2024 2:34 PM] Humacyte Third Quarter 2024 Financial Results and Business Update [2024-11-08 08:00AM]
13-08-2024	PM		HUMA	Humacyte, Inc.	952.67	-0.27	-0.23	-0.22	Humacyte GAAP EPS of -$0.48 misses by $0.24 [8/13/2024 7:09 AM]	6.67	0.05 (0.83%)	6.62	0.0 (0.00%)	1.96 - 9.97	3,352,658	4,000,000	210,347
Biggest stock movers today: JBLU, GOLD, KEY, HUMA, and more [8/12/2024 10:10 AM] Humacyte GAAP EPS of -$0.48 misses by $0.24 [8/13/2024 7:09 AM]
10-05-2024	PM		HUMA	Humacyte, Inc.	537.07	-0.29	-0.23	-0.22	Humacyte GAAP EPS of -$0.29 misses by $0.06 [5/10/2024 7:02 AM]	4.70	0.18 (3.98%)	4.45	-0.07 (-1.55%)	1.96 - 4.86	1,626,321	1,110,000	35,145
Humacyte GAAP EPS of -$0.29 misses by $0.06 [5/10/2024 7:02 AM] Humacyte Q1 2024 Earnings Preview [5/9/2024 11:39 AM]
22-03-2024	PM		HUMA	Humacyte, Inc.	363.55	-0.24	-0.25	-0.21	Humacyte GAAP EPS of -$0.24 in-line [3/22/2024 7:02 AM]	3.33	-0.27 (-7.64%)	3.55	-0.05 (-1.39%)	1.96 - 5.60	1,106,548	910,000	33,469
Humacyte Q4 2023 Earnings Preview [3/21/2024 11:15 AM] Humacyte GAAP EPS of -$0.24 in-line [3/22/2024 7:02 AM] Humacyte GAAP EPS of -$0.24 in-line [3/22/2024 7:20 AM]
09-11-2023	AH		HUMA	Humacyte, Inc.	249.28	-0.25	-0.25	-0.25	Humacyte GAAP EPS of -$0.25 in-line [11/9/2023 5:10 PM]	2.35	0.14 (6.11%)	2.28	0.07 (3.17%)	1.96 - 5.60	695,998	680,000	7,580
Humacyte GAAP EPS of -$0.25 in-line [11/9/2023 5:10 PM]
14-08-2023	PM		HUMA	Humacyte, Inc.	352.35	-0.22	-0.22	-0.19	Humacyte GAAP EPS of -$0.22 [8/14/2023 11:33 AM]	4.04	0.77 (23.59%)	3.38	0.11 (3.36%)	1.96 - 5.60	1,860,342	370,000	7,844
Humacyte GAAP EPS of -$0.22 [8/14/2023 11:33 AM] Humacyte gains as Piper Sandler upgrades after Q2 results [8/14/2023 12:38 PM]
12-05-2023	PM	7:00 AM ET (May 12)	HUMA	Humacyte, Inc.	459.00	-0.22	-0.22	0.00	Humacyte GAAP EPS of -$0.36 misses by $0.15 [5/12/2023 7:07 AM]	3.97	-0.27 (-6.48%)	4.20	-0.04 (-1.06%)	1.96 - 6.38	274,302	430,000	18,940
Humacyte GAAP EPS of -$0.36 misses by $0.15 [5/12/2023 7:07 AM] Humacyte gains 10% after $160M funding from Oberland [5/12/2023 7:45 AM]
24-03-2023	PM	7:00 AM ET (Mar 24)	HUMA	Humacyte, Inc.	318.64	-0.21	-0.23	-0.22	Humacyte GAAP EPS of -$0.04 beats by $0.19 [3/24/2023 7:04 AM]	2.89	-0.20 (-6.47%)	3.20	0.11 (3.56%)	1.96 - 8.04	145,140	280,000	2,302
Humacyte GAAP EPS of -$0.04 beats by $0.19 [3/24/2023 7:04 AM] Humacyte stock dips after Q4 sees net loss, no grant revenue [3/24/2023 11:55 AM]
10-11-2022	PM	7:00 AM ET (Nov 10)	HUMA	Humacyte, Inc.	332.71	-0.25	-0.20	-0.50	Humacyte GAAP EPS of -$0.25 misses by $0.04, revenue of $0.03M misses by $0.17M [11/10/2022 7:05 AM]	3.21	0.07 (2.23%)	3.13	-0.01 (-0.32%)	3.02 - 12.22	255,480	340,000	8,570
Humacyte Q3 2022 Earnings Preview [11/9/2022 1:10 PM] Humacyte GAAP EPS of -$0.25 misses by $0.04, revenue of $0.03M misses by $0.17M [11/10/2022 7:05 AM] Humacyte Third Quarter 2022 Financial Results and Business Update [Nov-10-22 07:00AM]
12-08-2022	PM	7:00 AM ET (Aug 12)	HUMA	Humacyte, Inc.	354.85	-0.19	-0.22	0.00	Humacyte GAAP EPS of $0.35, revenue of $1.3M [8/12/2022 7:07 AM]	4.58	0.18 (4.09%)	4.33	-0.07 (-1.59%)	3.07 - 17.45	1,007,386	580,000	15,500
Humacyte GAAP EPS of $0.35, revenue of $1.3M [8/12/2022 7:07 AM] Humacyte Second Quarter 2022 Financial Results and Business Update [Aug-12-22 07:00AM]
13-05-2022	PM	7:00 AM ET (May 13)	HUMA	Humacyte, Inc.	537.68	-0.22	-0.20	0.00	Humacyte reports Q1 results [5/13/2022 7:23 AM]	5.36	0.32 (6.35%)	5.30	0.26 (5.16%)	4.37 - 17.45	341,336	390,000	336
Humacyte reports Q1 results [5/13/2022 7:23 AM] Humacyte First Quarter 2022 Financial Results and Business Update [May-13-22 07:00AM]
29-03-2022	PM	7:30 AM ET (Mar 29)	HUMA	Humacyte, Inc.	664.37	-0.22	-0.19	0.00	Humacyte GAAP EPS of $0.41 beats by $0.61, revenue of $0.18M misses by $0.07M [3/29/2022 7:10 AM]	6.74	0.37 (5.81%)	6.38	0.01 (0.16%)	4.37 - 17.45	361,709	420,000	201
Humacyte Q4 2021 Earnings Preview [3/28/2022 1:16 PM] Humacyte GAAP EPS of $0.41 beats by $0.61, revenue of $0.18M misses by $0.07M [3/29/2022 7:10 AM] Humacyte Reports Fourth Quarter and Year End 2021 Financial Results and Provides Business Update [Mar-29-22 07:00AM] Do Institutions Own Humacyte, Inc. (NASDAQ:HUMA) Shares? [Mar-29-22 04:06PM]